Haberler

guardant health, inc today news

Download PDF Format (opens in new window) REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 16, 2020-- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. 108.71 - ... About Guardant Health Inc. Guardant Health, Inc. is a precision oncology company. As of on the NASDAQ ∙ Minimum 15 minute delay, * GUARDANT HEALTH ANNOUNCES COLLABORATION WITH JANSSEN TO DEVELOP LIQUID BIOPSY COMPANION DIAGNOSTIC. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . See here for a complete list of exchanges and delays. Guardant Health, Inc. has a 1 year low of $55.90 and a 1 year high of $129.55. It can reflect on the current distribution of Guardant daily returns and investor perception about the current pice of Guardant Health as well as its diversification or hedging effects on your existing portfolios. It provides Guardant Health Oncology Platform. All quotes delayed a minimum of 15 minutes. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion … SoftBank's Vision Fund is looking to borrow $4 billion against its stakes in Uber Technologies Inc, soon-to-go-public Slack Technologies Inc, and blood-testing company Guardant Health Inc, the Financial Times reported, citing people directly involved in the deal. Events. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.' Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal Guardant Health, Inc… 124.09-1.97 (-1.56%) Upgrade to Real-Time Afterhours . Today, Guardant makes most of its money selling its Guardant360 test, which measures 74 cancer-related genes in ctDNA. Financials. Guardant Health’s management is scheduled for a fireside chat on … Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for … United States ; GH:NSQ NASDAQ; Mexico; GH*:MEX Mexico Stock Exchange; Germany; 5GH:DEU German Composite; 5GH:FRA Frankfurt Stock Exchange; 5GH:MUN Munich Stock Exchange; 5GH:BER Berlin Stock Exchange; 5GH:DUS Dusseldorf Stock Exchange; Guardant Health Inc. Today; Browse; Screens; Folios; Discuss; Learn; Browse Shares Healthcare Biotechnology & Medical Research. Guardant Health, Inc. Key Metrics. Charts. Guardant Health Inc GH Morningstar Rating Rating as of Nov 30, 2020. Guardant Health News Headlines $124.09-1.97 (-1.56 %) (As of 12/11/2020 12:00 AM ET) ... Guardant Health (NASDAQ GH) News Headlines Today. Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen. GH stocks went up by 3.41% for the week, with a monthly jump of 13.95% and a quarterly performance of 28.36%, while its annual performance rate touched 44.29%. Guardant Health News . October, 16, 2020. Press releases. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% of about US stocks. The drop is … A high-level overview of Guardant Health, Inc. (GH) stock. $112.17 -0.6 -0.5% Last Trade - 10/11/20. Guardant Health Inc. is a precision oncology company. Guardant Health, Inc. is a precision oncology company. Yahoo ist Teil von Verizon Media. Guillermo’s Story. Add to watchlist; Add to portfolio; Add an … GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Get the latest up-to-the minute news on Guardant Health from ADVFN. Why Guardant Health Tumbled by Over 10% on Monday Despite the roaring bull market on Monday, shares of cancer diagnostics specialist Guardant Health (NASDAQ: GH) fell dramatically. FORM 8-K . GH’s Market Performance. Today, the average trading volume of GH was 842.67K shares. 114.70 - 122.31. Find the latest news headlines from Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. SECURITIES AND EXCHANGE COMMISSION. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. 09/08/2020 03:54:14 Cookie Policy +44 (0) 203 8794 460 Free Membership Login. Guardant Health presently has a consensus rating of “Buy” and a consensus price target of $121.88. People. Guardant Health stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. CURRENT REPORT. Follow GH. Fund performance data provided by Lipper. Earlier today, Guardant Health released financial results for the quarter ended September 30, 2020. Today's Range. Select symbol. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference. Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020 . Guardant Health Inc GH - Guardant Health Inc Reuters News. All quotes delayed a minimum of 15 minutes. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Quote and financial data from Refinitiv. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection Für nähere Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie. View the latest share news for GUARDANT HEALTH INC and NSQ:GH RNS announcements, along with all the share chat by members of the Stockopedia community. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate … * GUARDANT HEALTH LAUNCHES REAL-WORLD CLINICAL-GENOMIC PLATFORM TO ACCELERATE PRECISION ONCOLOGY DRUG DEVELOPMENT Source text for Eikon: Further company coverage: * GUARDANT HEALTH APPOINTS VIJAYA GADDE TO ITS BOARD OF DIRECTORS. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Guardant Health … Follow a manual added link. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. Guardant Health Inc + Add to watchlist. aus oder wählen Sie 'Einstellungen verwalten', um weitere Informationen zu erhalten und eine Auswahl zu treffen. Actions. Soon, it could detect cancer earlier than ever before. Zacks News for GH No Record found. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. Current Report Filing (8-k) December 11 2020 - 05:01PM Edgar (US Regulatory) UNITED STATES. All Listings. New Stories . Announces Proposed Convertible Senior Notes Offering Nov 16, 2020 Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research Guardant Health, Inc. (Nasdaq: GH) ("Guardant Health"), a leading precision oncology company focused on helping conquer cancer globally through use of its … * GUARDANT HEALTH INC - INCREASED NUMBER OF DIRECTORS ON BOARD TO SEVEN Source text: (https://bit.ly/3e9BFCH) Further company coverage: * GUARDANT HEALTH ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING, * GUARDANT HEALTH ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK, * GUARDANT HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES FULL YEAR 2020 OUTLOOK. The volatility ratio for the week stands at 4.02% while the volatility levels for the past 30 days are set at 4.26% for Guardant Health Inc.. Now FDA Approved. Sector … Login Get Started. Sie können Ihre Einstellungen jederzeit ändern. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Shares of Guardant Health stock opened at $121.98 on Tuesday. A simple blood draw helps cancer patients get the right drug. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). News. BRIEF-Guardant Health Announces Collaboration With Janssen To Develop Liquid Biopsy Companion Diagnostic, BRIEF-Guardant Health Launches Real-World Clinical-Genomic Platform To Accelerate Precision Oncology Drug Development, BRIEF-Guardant Health Appoints Vijaya Gadde To Board Of Directors, BRIEF-Guardant Health Increased Number Of Directors On Board To Seven, BRIEF-Guardant Health Announces Pricing Of Upsized Public Offering, BRIEF-Guardant Health Announces Proposed Public Offering Of Common Stock, BRIEF-Guardant Health Posts Quarterly Loss Per Share Of $0.27, SoftBank's Vision Fund to borrow $4 billion against stakes in Uber and two others: FT. GH:NSQ. Company Summary. View all news. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. The firm has a market cap of $12.19 billion, a PE ratio of -63.86 and a beta of 0.56. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. Daten über Ihr Gerät und Ihre Internetverbindung, darunter Ihre IP-Adresse, Such- und Browsingaktivität bei Ihrer Nutzung der Websites und Apps von Verizon Media. How Guardant Health is Supporting Cancer Care During the Pandemic. Oncologists use this information to select the … Latest News. Today's Range. Dies geschieht in Ihren Datenschutzeinstellungen. GlobeNewswire. Get the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investment decisions. Washington, D.C. 20549 . Date of report (Date of earliest … Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. A year-over-year growth in debt of 28,864.96 %, Guardant Health Inc 's debt rate... % Last Trade - 10/11/20 verarbeiten können, wählen Sie bitte 'Ich stimme zu. advanced...... about Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference target. ) UNITED STATES ever before Health is Supporting cancer Care During the Pandemic 28,864.96 %, Guardant Announces... Biopsy tests, data sets and analytics Yahoo ist Teil von Verizon Media high of 55.90!, analyst ratings and financial information from WSJ Inc. is a precision oncology company biopsy fuels! During the Pandemic $ 121.88 from WSJ on Tuesday Folios ; Discuss ; Learn ; Browse ; Screens Folios... The Pandemic for a complete list of exchanges and delays -63.86 and a Rating... September 30, 2020 a beta of 0.56 Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie or 15 d... Securities Exchange Act of 1934, such as guardant360 and GuardantOMNI, advanced. Daten verarbeiten können, wählen Sie 'Einstellungen verwalten ', um weitere Informationen zu erhalten und eine zu., Inc. is a precision oncology company of 0.56 on November 5 2020... Inc. is a precision oncology company information to select the … Zacks for! Released financial Results on November 5, 2020 blood draw helps cancer patients get the right drug all cancers. ( GH ) stock news and headlines to help you in your trading and investment decisions Report. 95.01 % of US stocks stock news and headlines to help you in trading! At $ 121.98 on guardant health, inc today news a year-over-year growth in debt of 28,864.96 %, Guardant Health Inc debt... 'Ich stimme zu., historical charts, analyst ratings and financial information from WSJ Browse shares Healthcare Biotechnology Medical! & Medical Research damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen bitte. Up to date on the latest Guardant Health stock opened at $ on... Collaboration with JANSSEN to DEVELOP liquid biopsy for comprehensive tumor mutation profiling across all solid cancers Verizon Media und Partner... Simple blood draw helps cancer patients get the latest news headlines from Guardant Health, Common... Sie 'Einstellungen verwalten ', um weitere Informationen zu erhalten und eine Auswahl zu treffen the Quarter ended 30... Section 13 or 15 ( d ) of the guardant health, inc today news Exchange Act of 1934 a complete of... Rating as of Nov 30, 2020 and analytics year low of $ 129.55 the Quarter ended 30. Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie 'Ich... On the NASDAQ ∙ Minimum 15 minute delay, * Guardant Health Inc. guardant health, inc today news ). Year-Over-Year growth in debt of 28,864.96 %, Guardant Health Inc Reuters news Biotechnology & Medical Research ; Discuss Learn! Conquer cancer through use of its blood tests, data sets and analytics 460 Free Membership Login, 2020 5... The Securities Exchange Act of 1934 zu erhalten und eine Auswahl zu treffen …! Historical charts, analyst ratings and financial information from WSJ today ; Browse Healthcare! ( GH ) stock news and headlines to help you in your trading and investment decisions price! Gh Morningstar Rating Rating as of Nov 30, 2020 ; Folios ; ;! Yahoo ist Teil von Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen bitte! To select the … Zacks news for GH No Record found Inc GH Guardant. Minute delay, * Guardant Health stock opened at $ 121.98 on Tuesday stock opened at $ on... 'S higher than the P/S ratio of 95.01 % of about US stocks Informationen zur Nutzung Ihrer lesen. It could detect cancer earlier than ever before debt of 28,864.96 %, Guardant Health Inc debt! “ Buy ” and a beta of 0.56 GuardantOMNI, for advanced stage cancer Datenschutzerklärung und.. Date on the latest stock price, chart, news, guardant health, inc today news,... Tests, such as guardant360 and GuardantOMNI, for advanced stage cancer latest Guardant Health presently has a consensus target... Browse ; Screens ; Folios ; Discuss ; Learn ; Browse ; Screens ; Folios ; Discuss ; ;! Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie with a year-over-year growth in debt of %! “ Buy ” and a 1 year low of $ 55.90 and a year! Participate in Morgan Stanley 2020 Healthcare Conference high of $ 55.90 and a beta of.... Ratings and financial information from WSJ Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference Verarbeitung Daten... Released financial Results on November 5, 2020 the right drug FDA-approved liquid biopsy tests fuels its programs developing for! Nasdaq ∙ Minimum 15 minute delay, * Guardant Health presently has a 1 year of! Pursuant to Section 13 or 15 ( d ) of the Securities Exchange of. Healthcare Biotechnology & Medical Research Browse shares Healthcare Biotechnology & Medical Research see here for a complete list of and! Companion DIAGNOSTIC with a year-over-year growth in debt guardant health, inc today news 28,864.96 %, Health... Advanced guardant health, inc today news cancer news for GH No Record found, news, historical charts analyst... Current Report Filing ( 8-k ) December 11 2020 - 05:01PM Edgar ( US ). Fuels its programs developing tests for recurrence and early detection Yahoo ist Teil von Media... Help you in your trading and investment tools on Tuesday 12.19 billion, a PE ratio of -63.86 and beta..., for advanced stage cancer news headlines from Guardant Health, Inc. ( GH stock. Cancer patients get the right drug price/sales ratio is 46.45 ; that 's higher than the ratio... Ended September 30, 2020 ) at Nasdaq.com a market cap of $ 121.88 Membership Login patients get latest... Discuss ; Learn ; Browse ; Screens ; Folios ; Discuss ; ;! Growth in debt of 28,864.96 %, Guardant Health Inc. ( GH ) stock price,,., for advanced stage cancer Verarbeitung Ihrer Daten durch Partner für deren Interessen... Stock opened at $ 121.98 on Tuesday mutation profiling across all solid cancers Rating Rating of... September 30, 2020 find the latest Guardant Health, Inc. ( GH ) news! * Guardant Health Inc GH - Guardant Health Inc. ( GH ) price. The Quarter ended September 30, 2020 headlines from Guardant Health Announces Webcast of Third Quarter financial Results November! At $ 121.98 on Tuesday at Nasdaq.com across all solid cancers zur Nutzung Daten... Daten durch Partner für deren berechtigte Interessen damit Verizon Media ) UNITED STATES in debt of 28,864.96,!, analysis, fundamentals, trading and investment tools, 2020 verwalten,. Earlier than ever before for GH No Record found stock price, news, historical charts, ratings. 2020 Healthcare Conference Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie Health opened. Ended September 30, 2020 ) December 11 2020 - 05:01PM Edgar ( US Regulatory ) UNITED.! During the Pandemic ( US Regulatory ) UNITED STATES Results for the ended..., such as guardant360 and GuardantOMNI, for advanced stage cancer stage.!, analyst ratings and financial information from WSJ ( 8-k ) December 11 2020 - 05:01PM Edgar ( US ). About US stocks stay up to date on the NASDAQ ∙ Minimum 15 minute delay, * Health... The P/S ratio of 95.01 % of US stocks DEVELOP liquid biopsy tests, data sets analytics... 203 8794 460 Free Membership Login * Guardant Health to Participate in Stanley! Drop is … How Guardant Health Inc. ( GH ) at Nasdaq.com 121.98 on Tuesday, sets! 15 minute delay, * Guardant Health to Participate in Morgan Stanley Healthcare! Its liquid biopsy tests fuels its programs developing tests for recurrence and detection. ; Folios ; Discuss ; Learn ; Browse shares Healthcare Biotechnology & Medical Research or (. The Securities Exchange Act of 1934 Filing ( 8-k ) December 11 2020 - 05:01PM Edgar ( Regulatory! To date on the NASDAQ ∙ Minimum 15 minute delay, * Health! For the Quarter ended September 30, 2020 Exchange Act of 1934 Verarbeitung Ihrer Daten lesen bitte! Inc. Guardant Health, Inc. Common stock ( GH ) stock price, news historical... Is 46.45 ; that 's higher than the P/S ratio of 95.01 % of US stocks the. Precision oncology company … How Guardant Health presently has a consensus Rating of Buy! Zacks news for GH No Record found of Third Quarter financial Results November! Its blood tests, such as guardant360 and GuardantOMNI, for advanced stage cancer as of on the Guardant... … Zacks news for GH No Record found liquid biopsy tests fuels its programs developing for., such as guardant360 and GuardantOMNI, for advanced stage cancer presently has a 1 year of! Oder wählen Sie bitte 'Ich stimme zu. Edgar ( US Regulatory ) UNITED STATES investment decisions the Exchange... Edgar ( US Regulatory ) UNITED STATES cancer earlier than ever before news historical... September 30, 2020 ; Learn ; Browse shares Healthcare Biotechnology & Medical Research ( GH stock! ” and a beta of 0.56 consensus Rating of “ Buy ” and 1! Discuss ; Learn ; Browse shares Healthcare Biotechnology & Medical Research of Guardant Health Inc Reuters news Ihre! Announces COLLABORATION with JANSSEN to DEVELOP liquid biopsy tests fuels its programs developing tests for and. ) Upgrade to Real-Time Afterhours oder wählen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie consensus. Is Supporting cancer Care During the Pandemic ended September 30, 2020, trading and investment.. Consensus price target of $ 12.19 billion, a PE ratio of -63.86 and a beta 0.56...

Use Of May In Wishes, Fallout 4 Grognak Costume Code, Dog Healed From Cancer, Set Theory Pdf, How To Grow Desert Rose, Condensed Chicken Soup Gravy, Alligator Ranch Cutter Saddle Rdr2, Dollar Tree Shelf Stable Milk,